SISVEL
Sisvel has expanded the scope of its LTE patent pool to offer patent licenses covering all LTE and LTE-Advanced specifications, representing comprehensive coverage of the latest versions of the 4G standard for mobile communications. The patent portfolio includes essential patents owned by Airbus DS , an Airbus Group company, the China Academy of Telecommunication Technology (CATT) , the Electronics and Telecommunications Research Institute (ETRI) , Orange (formerly France Telecom), TDF , KPN , and Bräu as well as patents originally owned by Nokia that Sisvel acquired in late 2011 . Sisvel is available to discuss membership with owners of essential LTE patents that may be interested in joining the group as a licensor.
The patent license covers the most recent LTE and LTE-Advanced specifications without any additional changes to the terms and conditions set for the license previously offered only for the LTE patent portfolio, providing for the same running royalty rate of 0.99 Euros per device.
Luc Savage, Director Intellectual Property and Licensing of Orange explained that “the broader scope of the pool confirms the group’s commitment to maximize the value which our license will provide to implementers of LTE technology.”
"This expansion demonstrates that Sisvel's LTE pool has adapted to developments in the technical and commercial landscapes," noted Karel van Lelyveld, CEO of Sisvel International, "and we remain well-positioned for all companies advocating lower aggregate royalty rates for the benefit of the LTE industry to participate in this joint effort rather than undertaking individual license negotiations."
Sisvel invites potential licensees to get into contact with Sisvel to obtain further information regarding the LTE-portfolio license. Obtaining a license from the LTE-pool at the early stage of this licensing program will include the benefit of a reduced royalty rate for all the early licensees.
You may contact Sisvel at the following e-mail address: LTE@sisvel.com .
About Sisvel
Started in 1982 when Sisvel S.p.A. was founded in Italy, the Sisvel Group has become a world leader in managing intellectual property and maximizing the value of patent rights. The Sisvel Group is global in scope and reach, with companies in Italy (Sisvel in None Torinese and Edico in Rome), the United States (Sisvel US and Audio MPEG in Metropolitan Washington, DC), China (Sisvel Hong Kong), Japan (Sisvel Japan in Tokyo), Germany (Sisvel Germany in Stuttgart), Luxembourg (Sisvel International), and the United Kingdom (Sisvel UK in London), with over one hundred professionals worldwide with engineers, legal, and licensing expertise. Sisvel has a long history of managing successful patent portfolios including those related to the audio compression standards known as MP3 and MPEG Audio, and widespread technologies such as OSD (On Screen Display), ATSS (Automatic Tuning & Sorting System), and WSS (Wide Screen Signaling - for automatic switching of television image formats). Sisvel currently operates patent pools for the DVB-T, DVB-T2, DVB-C2, LTE and Wi-Fi standards, together with its Sisvel Wireless licensing program.
For additional information, please visit www.sisvel.com
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150420005080/en/
Contact:
Media Contact Sisvel Group
Veronica Pugi, Tel: + 39 011 990
4114
Senior Communications Officer
veronica.pugi@sisvel.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 22:32:00 CEST | Press release
Successful Transaction Marks Another Milestone in A-CAP’s Soccer Club Portfolio Strategy Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 20:00:00 CEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum